InsidersTradesSigma
Pharming Group N.V.: management transactions · Netherlands · AFM
AFM:pharming-group-nvNL·AFMMcap 783M€Healthcare & Pharma
Browse the full insider trade history of Pharming Group N.V., a listed issuer based in Netherlands. Shares are listed on NL NL, under the oversight of AFM. Operating in the Healthcare & Pharma sector, Pharming Group N.V. has published 116 insider filings. Market capitalisation: €783.2m. The latest transaction was disclosed on 12 March 2026 — Purchase. Among the most active insiders: S. de Vries. Every trade is accessible without an account.
116
Insider Decl.
0
Thresholds
€88m
105 ops.
Buy Volume
€398,700
4 ops.
Sell Volume
Financial data
Analyst consensus
4 analysts1.90 €Target 2.23 €2.61 €
Income statement
Revenue376.1 M€
Gross profit330.6 M€88% margin
Net income2.9 M€3.3% margin
Valuation
PER (trailing)55.5x
PER (forward)30.6x
P/Book3.3x
Beta0.12
Balance sheet & cash
Market cap783.2 M€
Total debt115.8 M€
Free Cash Flow54.0 M€
Debt / Equity43%
Profitability & ownership
ROE5.0%
ROA4.9%
% insiders1.9%
% institutions22.7%
Last declaration on 12 March 2026
Declarations116 total
Executives●Purchase9AFM
02,091,330 shares0
Restricted share
AFM:189920·
Ideal exit: 7 Dec 2026 (T+270)
Executives●Mixed9AFM
0-255,825 shares0
Restricted share
AFM:187617·
Executives●Purchase9AFM
03,613 shares0
Gewoon aandeel
AFM:183064·
Ideal exit: 3 Aug 2026 (T+270)
Executives●Purchase9AFM
017,550 shares0
Gewoon aandeel
AFM:176307·
Ideal exit: 8 Mar 2026 (T+270)
Executives●Purchase9AFM
031,400 shares0
Gewoon aandeel
AFM:176244·
Ideal exit: 7 Mar 2026 (T+270)
Executives●Purchase9AFM
031,400 shares0
Gewoon aandeel
AFM:176243·
Ideal exit: 7 Mar 2026 (T+270)
Executives●Purchase9AFM
03,614,572 shares0
Restricted share
AFM:171687·
Ideal exit: 7 Dec 2025 (T+270)
Executives●Purchase9AFM
01,023,302 shares0
Restricted share
AFM:171449·
Ideal exit: 2 Dec 2025 (T+270)
Executives●Purchase9AFM
08,487 shares0
Gewoon aandeel
AFM:165350·
Ideal exit: 28 Jul 2025 (T+270)
Executives●Purchase9AFM
08,487 shares0
Gewoon aandeel
AFM:165349·
Ideal exit: 28 Jul 2025 (T+270)
Executives●Purchase9AFM
08,487 shares0
Gewoon aandeel
AFM:161829·
Ideal exit: 28 Apr 2025 (T+270)
Executives●Purchase9AFM
08,487 shares0
Gewoon aandeel
AFM:161830·
Ideal exit: 28 Apr 2025 (T+270)
Executives●Purchase9AFM
09,553 shares0
Gewoon aandeel
AFM:159044·
Ideal exit: 23 Feb 2025 (T+270)
Executives●Purchase9AFM
09,553 shares0
Gewoon aandeel
AFM:159046·
Ideal exit: 23 Feb 2025 (T+270)
25 of 116 declarations
About Pharming Group N.V.
Pharming Group N.V. is a biopharmaceutical company focused on developing treatments for rare diseases. It is listed on the Amsterdam Stock Exchange (XAMS).
